Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
About Us
Conferences
Videos
Webinars
Media & Press
Top Story
COVID-19
Pandemic played out in vastly different ways across the U.S.: Study
A state-by-state analysis of COVID-19 impacts across the U.S. revealed the forces driving wide variations in health, education, and economic performance.
Featured
COVID-19
Frequent COVID-19 testing of nursing home staff saved lives: Study
Cervical Cancer
Mailing HPV self-sampling kits for cervical cancer screening was cost-effective in study
Latest News
Ohio, Kentucky doctors convicted in scheme to bill Medicaid for millions of dollars in unnecessary urinalysis testing
March 24, 2023
Impact of circadian rhythms on cellular functions points to better ways to treat cancer
March 24, 2023
U.S. IVD market reaches $53 billion
March 22, 2023
RNA-seq analysis links protein to spread of pancreatic cancer, reveals potential drug target
March 23, 2023
Stay in the Know
Delivered right to your inbox, LabPulse’s newsletters keep you informed on the latest clinical lab updates. Subscribe to get exclusive access!
Sign Up
Business Insights
Business Insights
U.S. IVD market reaches $53 billion
Trends and Finance
Patients prefer immediate test results, even when the news is bad
Financial Results
LumiraDx Q4 revenues drop 65% on lower COVID-19 testing
Trends and Finance
Point-of-care test developer Proxim Diagnostics obtains strategic investment from BioMérieux
Diagnostic Technologies
Sequencing
RNA-seq analysis links protein to spread of pancreatic cancer, reveals potential drug target
Cervical Cancer
Mailing HPV self-sampling kits for cervical cancer screening was cost-effective in study
Neurodegenerative Disease
CND Life Sciences, Beth Israel sign agreement on skin-based testing technology for neurodegenerative diseases
Product Launch
Quest launches long-COVID testing panels for consumers
Diseases
COVID-19
Pandemic played out in vastly different ways across the U.S.: Study
COVID-19
Frequent COVID-19 testing of nursing home staff saved lives: Study
Cancer
Impact of circadian rhythms on cellular functions points to better ways to treat cancer
Business Insights
U.S. IVD market reaches $53 billion
More from LabPulse.com
Rapid nirmatrelvir treatment in study reduced long-COVID risk
Nirmatrelvir treatment soon after a positive SARS-CoV-2 test result may reduce the chances of developing long COVID in people with risk factors.
March 23, 2023
Bionano announces study findings for optical genome mapping of rare reproductive system disorder
MRKH results in the absence or underdevelopment of female reproductive organs; a secondary type of the disorder is also associated with skeletal, auditory, and cardiac valve abnormalities.
March 22, 2023
Quest Diagnostics offers suite of services for transplant patients and living donors
The offerings of the Quest Advanced Specialized Transplant Services suite include access to Quest’s national network of service centers and mobile phlebotomists for both recipients and living donors in the 48 contiguous U.S. states.
March 23, 2023
CND Life Sciences, Beth Israel sign agreement on skin-based testing technology for neurodegenerative diseases
The agreement with Beth Israel Deaconess Medical Center aims to solidify important technology for CND’s Syn-One Test, a skin-based test that aids the diagnosis of synucleinopathies, a family of neurodegenerative disorders.
March 22, 2023
Quest launches long-COVID testing panels for consumers
The panels could be used by any of the millions of Americans that still suffer from lingering COVID-19 side effects, Quest said.
March 22, 2023
Roche, Lilly partner on early diagnosis of Alzheimer's disease
The firms are developing one of Roche's panels, which measures phosphorylated Tau (pTau) 181 protein and apolipoprotein (APOE) E4 in human blood plasma.
March 22, 2023
Most Popular
Quest launches long-COVID testing panels for consumers
Ohio, Kentucky doctors convicted in scheme to bill Medicaid for millions of dollars in unnecessary urinalysis testing
RNA-seq analysis links protein to spread of pancreatic cancer, reveals potential drug target
Patients prefer immediate test results, even when the news is bad
Point-of-care test developer Proxim Diagnostics obtains strategic investment from BioMérieux
Quest Diagnostics offers suite of services for transplant patients and living donors
More from LabPulse.com
Contagious fungal infections increase dramatically
Candidiasis infections caused by Candida auris, a highly contagious fungus, rose dramatically between 2019 and 2021, reflecting increased transmission.
March 21, 2023
Guardant Health, Ohio State University study colorectal cancer screening adherence
The Ohio State University-led study will evaluate changes in CRC screening adherence in underserved urban and rural communities. Guardant Health is providing its Shield blood test to eligible individuals through mobile health clinic partners.
March 21, 2023
Patients prefer immediate test results, even when the news is bad
In a recent survey, patients overwhelmingly preferred receiving their test results immediately, even if their provider had not yet reviewed them.
March 21, 2023
Invitae partners with Epic on workflow for genetic testing results
Invitae will make its genetic tests results available through Aura in the usual workflows of providers in Epic’s community.
March 21, 2023
LumiraDx Q4 revenues drop 65% on lower COVID-19 testing
The firm recorded an accounting impairment in Q4 for excess manufacturing and inventory related to the scale-up during peak COVID-19 testing demand and the decision to pause commercialization of its Amira COVID-19 test.
March 21, 2023
Gestational diabetes rise linked to screening practices
Although gestational diabetes is reportedly on the rise, a study finds that changes in screening practices may explain much of the increase.
March 20, 2023
